Skip to Main Content
DownloadHi-Res Photo

Veronica Chiang, MD, FAANS

Professor of Neurosurgery; Associate Vice Chair of Academic Affairs; Director, Stereotactic Radiosurgery; Director, Gamma Knife Center, YNHH; Director, Stereotactic Radiosurgery Fellowship

Contact Information

Veronica Chiang, MD, FAANS

Office Location

Mailing Address

  • PO Box 208082

    New Haven, CT 06520-8082

    United States

Related Links

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

Dr. Chiang's research interests include:

1. clinical outcomes and paradigm changes in multidisciplinary management of patients with metastatic brain tumors
2. imaging changes following stereotactic radiosurgery to brain tumors

3. role of laser thermocoagulation and radiosurgery in management of patients with brain metastases

Specialized Terms: Brain Tumor; Cancer; Cerebral Metastases; Clinical Outcomes; Radiation Side Effects; Radiosurgery

Research Interests

Brain Neoplasms; Neoplasm Metastasis; Neurosurgery; Radiation Effects; Radiosurgery; Radiation Oncology

Clinical Trials

ConditionsStudy Title
Brain and Nervous SystemPhase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 3 Study to Establish the Diagnostic Performance of 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy
An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy
LungDetermining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer
Diseases of the Nervous SystemLaser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN)
Brain and Nervous System; Lung; Melanoma, skinA Phase II Trial of Pembrolizumab Plus Bevacizumab in Patients With Metastatic Melanoma or Non-small Cell Lung Cancer With Untreated Brain Metastases
Edit Profile